Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Breast Cancer
Title
TRIO B-09. Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
Description
TRIO B-09
Phase 1b/2 single-arm trial evaluating the combination of lapatinib, everolimus and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with CNS progression after trastuzumab.
IRB Number
NCT01783756
Inclusion/Notes

Please contact the Reseach department for details of study eligibility.

For more information, please click here: http://clinicaltrials.gov/ct2/show/NCT01783756

Status
Open to Enrollment
Principal Investigator
Julie Taguchi, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.